PANI, Luca
PANI, Luca
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
(-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors
2001 Castelli M., Paola; Mocci, I.; Sanna, A. M.; Gessa, G. L.; Pani, L.
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice
2010 Luongo, L.; Palazzo, E.; Tambaro, S.; Giordano, C.; Gatta, L.; Scafuro, M. A.; Rossi, F. s.; Lazzari, P.; Pani, L.; de Novellis, V.; Malcangio, M.; Maione, S.
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors
2007 Loriga, G.; Ruiu, S.; Manca, I.; Murineddu, G.; Dessi, C.; Pani, L.; Pinna, G. A.
A case-control study of visually evoked postural responses in childhood with primary headaches
2020 Baraldi, C; Gherpelli, C; Alicandri Ciufelli, M.; Monzani, D.; Pini, L. A.; Pani, L.; Guerzoni, S.
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats
2010 Marchese, G.; Pittau, B.; Casu, G.; Peddio, G.; Spada, G. P.; Pira, M.; Deriu, A.; Portesani, F.; Pisu, C.; Lazzari, P.; Pani, L.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
2022 Sforzini, L.; Worrell, C.; Kose, M.; Anderson, I. M.; Aouizerate, B.; Arolt, V.; Bauer, M.; Baune, B. T.; Blier, P.; Cleare, A. J.; Cowen, P. J.; Dinan, T. G.; Fagiolini, A.; Ferrier, I. N.; Hegerl, U.; Krystal, A. D.; Leboyer, M.; McAllister-Williams, R. H.; Mcintyre, R. S.; Meyer-Lindenberg, A.; Miller, A. H.; Nemeroff, C. B.; Normann, C.; Nutt, D.; Pallanti, S.; Pani, L.; Penninx, B. W. J. H.; Schatzberg, A. F.; Shelton, R. C.; Yatham, L. N.; Young, A. H.; Zahn, R.; Aislaitner, G.; Butlen-Ducuing, F.; Fletcher, C.; Haberkamp, M.; Laughren, T.; Mantyla, F. -L.; Schruers, K.; Thomson, A.; Arteaga-Henriquez, G.; Benedetti, F.; Cash-Gibson, L.; Chae, W. R.; De Smedt, H.; Gold, S. M.; Hoogendijk, W. J. G.; Mondragon, V. J.; Maron, E.; Martynowicz, J.; Melloni, E.; Otte, C.; Perez-Fuentes, G.; Poletti, S.; Schmidt, M. E.; van de Ketterij, E.; Woo, K.; Flossbach, Y.; Ramos-Quiroga, J. A.; Savitz, A. J.; Pariante, C. M.
A network study to differentiate suicide attempt risk profiles in male and female patients with major depressive disorder
2024 Sarti, P.; Colliva, C.; Varrasi, S.; Guerrera, C. S.; Platania, G. A.; Boccaccio, F. M.; Castellano, S.; Pirrone, C.; Pani, L.; Tascedda, F.; di Nuovo, S.; Caraci, F.; Blom, J. M. C.
A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire
2022 Guidetti, C.; Fava, M.; Pani, L.; Pappagallo, M.; Serra, G.; Demartin, S.; Mattarei, A.; Manfredi, P. L.
ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action
1993 Cavallaro, S.; Pani, L.; Guidotti, A.; Costa, E.
Adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions affects overall medication adherence in older persons: Evidence from the Italian nationwide osmed health-db database
2016 Marengoni, Alessandra; Onder, Graziano; Esposti, Luca Degli; Russo, Pierluigi; Sangiorgi, Diego; Buda, Stefano; Fini, Massimo; Marchionni, Niccol; Bonassi, Stefano; Mammarella, Federica; Marrocco, Walter; Pozzi, Giuseppe; Palmer, Katie; Monaco, Alessandro; Pecorelli, Sergio; Pani, Luca
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency
2016 Onder, G.; Marengoni, A.; Russo, P.; Degli Esposti, L.; Fini, M.; Monaco, A.; Bonassi, S.; Palmer, K.; Marrocco, W.; Pozzi, G.; Sangiorgi, D.; Buda, S.; Marchionni, N.; Mammarella, F.; Bernabei, R.; Pani, L.; Pecorelli, S.
Alternative pricing strategies for cancer drugs
2015 Messori, A.; De Rosa, M.; Pani, L.
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin
2015 Gianoncelli, A.; Bonini, S. A.; Bertuzzi, M.; Guarienti, M.; Vezzoli, S.; Kumar, R.; Delbarba, A.; Mastinu, A.; Sigala, S.; Spano, P.; Pani, L.; Pecorelli, S.; Memo, M.
Animal models of mania
1995 Gessa, G. L.; Pani, L.; Serra, G.; Fratta, W.
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache
2024 Guerzoni, S.; Castro, F. L.; Baraldi, C.; Brovia, D.; Tascedda, F.; Rivi, V.; Pani, L.
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression
1994 D'Aquila, P. S.; Collu, M.; Pani, L.; Gessa, G. L.; Serra, G.
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions
2010 Lazzari, P.; Fadda, P.; Marchese, G.; Casu, G. L.; Pani, L.
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy
2007 Pani, L.; Pira, L.; Marchese, G.
Anxious-excited depression. A mixed affective syndrome
1995 Koukopoulos, A.; Pani, L.; Serra, G.; Minnai, G.; Reginaldi, D.
Approaches to attenuated psychosis syndrome treatments: A perspective on the regulatory issues
2019 Pani, L.; Keefe, R. S. E.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
(-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors | 1-gen-2001 | Castelli M., Paola; Mocci, I.; Sanna, A. M.; Gessa, G. L.; Pani, L. | |
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice | 1-gen-2010 | Luongo, L.; Palazzo, E.; Tambaro, S.; Giordano, C.; Gatta, L.; Scafuro, M. A.; Rossi, F. s.; Lazzari, P.; Pani, L.; de Novellis, V.; Malcangio, M.; Maione, S. | |
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors | 1-gen-2007 | Loriga, G.; Ruiu, S.; Manca, I.; Murineddu, G.; Dessi, C.; Pani, L.; Pinna, G. A. | |
A case-control study of visually evoked postural responses in childhood with primary headaches | 1-gen-2020 | Baraldi, C; Gherpelli, C; Alicandri Ciufelli, M.; Monzani, D.; Pini, L. A.; Pani, L.; Guerzoni, S. | |
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats | 1-gen-2010 | Marchese, G.; Pittau, B.; Casu, G.; Peddio, G.; Spada, G. P.; Pira, M.; Deriu, A.; Portesani, F.; Pisu, C.; Lazzari, P.; Pani, L. | |
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials | 1-gen-2022 | Sforzini, L.; Worrell, C.; Kose, M.; Anderson, I. M.; Aouizerate, B.; Arolt, V.; Bauer, M.; Baune, B. T.; Blier, P.; Cleare, A. J.; Cowen, P. J.; Dinan, T. G.; Fagiolini, A.; Ferrier, I. N.; Hegerl, U.; Krystal, A. D.; Leboyer, M.; McAllister-Williams, R. H.; Mcintyre, R. S.; Meyer-Lindenberg, A.; Miller, A. H.; Nemeroff, C. B.; Normann, C.; Nutt, D.; Pallanti, S.; Pani, L.; Penninx, B. W. J. H.; Schatzberg, A. F.; Shelton, R. C.; Yatham, L. N.; Young, A. H.; Zahn, R.; Aislaitner, G.; Butlen-Ducuing, F.; Fletcher, C.; Haberkamp, M.; Laughren, T.; Mantyla, F. -L.; Schruers, K.; Thomson, A.; Arteaga-Henriquez, G.; Benedetti, F.; Cash-Gibson, L.; Chae, W. R.; De Smedt, H.; Gold, S. M.; Hoogendijk, W. J. G.; Mondragon, V. J.; Maron, E.; Martynowicz, J.; Melloni, E.; Otte, C.; Perez-Fuentes, G.; Poletti, S.; Schmidt, M. E.; van de Ketterij, E.; Woo, K.; Flossbach, Y.; Ramos-Quiroga, J. A.; Savitz, A. J.; Pariante, C. M. | |
A network study to differentiate suicide attempt risk profiles in male and female patients with major depressive disorder | 1-gen-2024 | Sarti, P.; Colliva, C.; Varrasi, S.; Guerrera, C. S.; Platania, G. A.; Boccaccio, F. M.; Castellano, S.; Pirrone, C.; Pani, L.; Tascedda, F.; di Nuovo, S.; Caraci, F.; Blom, J. M. C. | |
A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire | 1-gen-2022 | Guidetti, C.; Fava, M.; Pani, L.; Pappagallo, M.; Serra, G.; Demartin, S.; Mattarei, A.; Manfredi, P. L. | |
ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action | 1-gen-1993 | Cavallaro, S.; Pani, L.; Guidotti, A.; Costa, E. | |
Adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions affects overall medication adherence in older persons: Evidence from the Italian nationwide osmed health-db database | 1-gen-2016 | Marengoni, Alessandra; Onder, Graziano; Esposti, Luca Degli; Russo, Pierluigi; Sangiorgi, Diego; Buda, Stefano; Fini, Massimo; Marchionni, Niccol; Bonassi, Stefano; Mammarella, Federica; Marrocco, Walter; Pozzi, Giuseppe; Palmer, Katie; Monaco, Alessandro; Pecorelli, Sergio; Pani, Luca | |
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency | 1-gen-2016 | Onder, G.; Marengoni, A.; Russo, P.; Degli Esposti, L.; Fini, M.; Monaco, A.; Bonassi, S.; Palmer, K.; Marrocco, W.; Pozzi, G.; Sangiorgi, D.; Buda, S.; Marchionni, N.; Mammarella, F.; Bernabei, R.; Pani, L.; Pecorelli, S. | |
Alternative pricing strategies for cancer drugs | 1-gen-2015 | Messori, A.; De Rosa, M.; Pani, L. | |
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin | 1-gen-2015 | Gianoncelli, A.; Bonini, S. A.; Bertuzzi, M.; Guarienti, M.; Vezzoli, S.; Kumar, R.; Delbarba, A.; Mastinu, A.; Sigala, S.; Spano, P.; Pani, L.; Pecorelli, S.; Memo, M. | |
Animal models of mania | 1-gen-1995 | Gessa, G. L.; Pani, L.; Serra, G.; Fratta, W. | |
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache | 1-gen-2024 | Guerzoni, S.; Castro, F. L.; Baraldi, C.; Brovia, D.; Tascedda, F.; Rivi, V.; Pani, L. | |
Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression | 1-gen-1994 | D'Aquila, P. S.; Collu, M.; Pani, L.; Gessa, G. L.; Serra, G. | |
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions | 1-gen-2010 | Lazzari, P.; Fadda, P.; Marchese, G.; Casu, G. L.; Pani, L. | |
Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy | 1-gen-2007 | Pani, L.; Pira, L.; Marchese, G. | |
Anxious-excited depression. A mixed affective syndrome | 1-gen-1995 | Koukopoulos, A.; Pani, L.; Serra, G.; Minnai, G.; Reginaldi, D. | |
Approaches to attenuated psychosis syndrome treatments: A perspective on the regulatory issues | 1-gen-2019 | Pani, L.; Keefe, R. S. E. |